Md. Al Amin

521 total citations
44 papers, 320 citations indexed

About

Md. Al Amin is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Md. Al Amin has authored 44 papers receiving a total of 320 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 9 papers in Organic Chemistry and 8 papers in Pharmacology. Recurrent topics in Md. Al Amin's work include Computational Drug Discovery Methods (8 papers), Synthesis and biological activity (5 papers) and Bioactive Compounds and Antitumor Agents (3 papers). Md. Al Amin is often cited by papers focused on Computational Drug Discovery Methods (8 papers), Synthesis and biological activity (5 papers) and Bioactive Compounds and Antitumor Agents (3 papers). Md. Al Amin collaborates with scholars based in Bangladesh, United States and India. Md. Al Amin's co-authors include Md Sohel, Md. Arju Hossain, Habiba Sultana, Abdullah Al Mamun, Partha Biswas, Abdullah Al Mamun, Mohammad Nurul Amin, Md. Chayan Ali, Raju Dash and Md. Sharif Khan and has published in prestigious journals such as PLoS ONE, Scientific Reports and Molecules.

In The Last Decade

Md. Al Amin

30 papers receiving 315 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Md. Al Amin Bangladesh 9 128 49 44 32 32 44 320
Md. Arju Hossain Bangladesh 11 167 1.3× 48 1.0× 45 1.0× 30 0.9× 51 1.6× 42 402
Nazia Afroze Saudi Arabia 9 216 1.7× 59 1.2× 65 1.5× 31 1.0× 38 1.2× 13 377
Ritu Raina Saudi Arabia 10 221 1.7× 61 1.2× 60 1.4× 26 0.8× 31 1.0× 15 373
Shahenda Mahgoub Egypt 12 108 0.8× 35 0.7× 56 1.3× 37 1.2× 42 1.3× 26 404
Vinod Kumar Nelson India 12 156 1.2× 42 0.9× 60 1.4× 23 0.7× 66 2.1× 39 453
Sona Uramova Slovakia 7 164 1.3× 47 1.0× 37 0.8× 22 0.7× 43 1.3× 7 319
Kaneez Fatima India 9 143 1.1× 29 0.6× 25 0.6× 20 0.6× 47 1.5× 23 322
Vijaya Dubey India 10 157 1.2× 43 0.9× 44 1.0× 21 0.7× 41 1.3× 15 339
Kee Wee Tan China 8 204 1.6× 68 1.4× 30 0.7× 24 0.8× 46 1.4× 13 413
Vincenzo Vestuto Italy 14 177 1.4× 56 1.1× 33 0.8× 17 0.5× 61 1.9× 32 432

Countries citing papers authored by Md. Al Amin

Since Specialization
Citations

This map shows the geographic impact of Md. Al Amin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Md. Al Amin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Md. Al Amin more than expected).

Fields of papers citing papers by Md. Al Amin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Md. Al Amin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Md. Al Amin. The network helps show where Md. Al Amin may publish in the future.

Co-authorship network of co-authors of Md. Al Amin

This figure shows the co-authorship network connecting the top 25 collaborators of Md. Al Amin. A scholar is included among the top collaborators of Md. Al Amin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Md. Al Amin. Md. Al Amin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gupta, Jeetendra Kumar, Jyoti Singh, Pradip Chaudhari, et al.. (2025). Phytochemical‐Based Drug Discovery for Breast Cancer: Combining Virtual Screening and Molecular Dynamics to Identify Novel Therapeutics. Chemistry & Biodiversity. 22(6). e202402864–e202402864. 7 indexed citations
2.
Amin, Md. Al, Mehrukh Zehravi, Sherouk Hussein Sweilam, et al.. (2025). Alkaloids as neuroprotectors: targeting signaling pathways in neurodegenerative diseases. Molecular and Cellular Biochemistry. 480(8). 4587–4612. 8 indexed citations
3.
Amin, Md. Al, et al.. (2025). Bioinformatics-driven identification of pathogenic missense nsSNPs in the human proto-oncogene SRC and cancer susceptibility. Journal of Genetic Engineering and Biotechnology. 23(4). 100618–100618.
4.
Amin, Md. Al, et al.. (2025). Pharmacophore-guided computational modeling of quinolone-ATPase conjugate inhibitors targeting DNA GyrB subunit of Staphylococcus aureus. Computers in Biology and Medicine. 186. 109727–109727. 2 indexed citations
5.
Mohiuddin, A. K. M., et al.. (2025). Designing siRNA for silencing the human ERBB2 gene in cancer treatment: Evaluating intracellular delivery strategies. Computers in Biology and Medicine. 186. 109663–109663. 3 indexed citations
6.
Amin, Md. Al, Mehrukh Zehravi, Sherouk Hussein Sweilam, et al.. (2025). Therapeutic potential of flavonoids in neuroprotection: brain and spinal cord injury focus. Naunyn-Schmiedeberg s Archives of Pharmacology. 398(7). 8215–8240. 10 indexed citations
8.
Amin, Md. Al, Mohamed H. Nafady, Mehrukh Zehravi, et al.. (2024). Flavonoids and Alzheimer’s disease: reviewing the evidence for neuroprotective potential. Molecular and Cellular Biochemistry. 480(1). 43–73. 10 indexed citations
9.
Hossain, Md. Arju, Md. Al Amin, Md. Arif Khan, et al.. (2024). Genome-Wide Investigation Reveals Potential Therapeutic Targets in Shigella spp.. BioMed Research International. 2024. 1–14. 5 indexed citations
10.
Amin, Md. Al, et al.. (2024). Engineering Novel Amphiphilic Platinum(IV) Complexes to Co-Deliver Cisplatin and Doxorubicin. Molecules. 29(17). 4095–4095.
11.
Shahen, Nur Hasan Mahmud, Md. Al Amin, Foyjonnesa, & R. Saidur. (2024). Soliton structures of fractional coupled Drinfel’d–Sokolov–Wilson equation arising in water wave mechanics. Scientific Reports. 14(1). 18894–18894. 7 indexed citations
12.
Amin, Md. Al, Mehrukh Zehravi, Sherouk Hussein Sweilam, et al.. (2024). Alkaloid-based modulators of the PI3K/Akt/mTOR pathway for cancer therapy: Understandings from pharmacological point of view. Chemico-Biological Interactions. 402. 111218–111218. 15 indexed citations
13.
Amin, Md. Al, Sherouk Hussein Sweilam, Jeetendra Kumar Gupta, et al.. (2024). Monoterpenoid synergy: a new frontier in biological applications. Naunyn-Schmiedeberg s Archives of Pharmacology. 398(1). 103–124. 11 indexed citations
14.
Hossain, Shakhawoat, et al.. (2023). Advancing Healthcare Outcomes with AI: Predicting Hospital Readmissions in the USA. 4(5). 94–109.
15.
Sohel, Md, Partha Biswas, Md. Al Amin, et al.. (2023). Exploring the anti‐cancer potential of dietary phytochemicals for the patients with breast cancer: A comprehensive review. Cancer Medicine. 12(13). 14556–14583. 41 indexed citations
16.
Amin, Md. Al, Talha Bin Emran, Mehrukh Zehravi, et al.. (2023). Research Progress of Indole Alkaloids: Targeting MAP Kinase Signaling Pathways in Cancer Treatment. Cancers. 15(22). 5311–5311. 2 indexed citations
17.
Sohel, Md, Partha Biswas, Md. Al Amin, et al.. (2022). Genistein, a Potential Phytochemical against Breast Cancer Treatment-Insight into the Molecular Mechanisms. Processes. 10(2). 415–415. 56 indexed citations
19.
Sohel, Md, Habiba Sultana, Md. Al Amin, et al.. (2022). Chemotherapeutic potential of hesperetin for cancer treatment, with mechanistic insights: A comprehensive review. Heliyon. 8(1). e08815–e08815. 68 indexed citations
20.
Amin, Md. Al, et al.. (2019). Microbiological quality analysis of commercial fruit juice in Dhaka City, Bangladesh. 8(1). 15–18. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026